Iovance Biotherapeutics Inc IOVA 深 滬
已收盤 05-22 16:00:00 美东时间
4.11
+0.410
+11.08%
華盛通- 最 高4.20
- 今 開3.70
- 成交量 2310.11万股
- 最 低 3.69
- 昨 收 3.70
- 總市值 18.35亿
- 52周最高 5.63
- 市盈率 靜 --
- 換手率 5.17%
- 52周最低 1.66
- 委 比 -56.05%
- 總股本 4.47亿
- 歷史最高 54.208
- 量 比 2.50
- 振 幅 13.78%
- 歷史最低 1.6385
- 每 手 1
- 風險率 0.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Iovance Biotherapeutics Signals Strong Momentum in Call
Iovance Biotherapeutics (($IOVA)) has held its Q1 earnings call. Read on for th...
05-09 09:28
财报速睇 | Iovance Biotherapeutics 2026财年Q1营收0.71亿美元，同比增长44.8%；归母净利润亏损0.79亿美元，同比亏损缩窄32.0%
华盛资讯5月7日讯，Iovance Biotherapeutics公布2026财年Q1业绩，公司Q1营收0.71亿美元，同比增长44.8%，归母净利润亏损0.79亿美元，同比亏损缩窄32.0%。
05-07 21:34
Iovance Biotherapeutics shares are trading lower after the company reported worse-than-expected Q1 financial results and issued FY26 sales guidance with its midpoint below estimates.
Iovance Biotherapeutics shares are trading lower after the company reported wor...
05-07 21:00
Iovance Biotherapeutics Sees FY2026 Sales $350.000M-$370.000M vs $370.477M Est
Iovance Biotherapeutics (NASDAQ:IOVA) sees FY2026 sales of $350.000 million-$370.000 million vs $370.477 million analyst estimate.
05-07 19:11
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance Biotherapeutics granted stock options for 3,400 shares to a new non-executive employee under its Amended 2021 Inducement Plan. Each option has an exercise price of $3.87 and vests over three years. The company focuses on innovative TIL therapies, with Amtagvi® being the first FDA-approved T-cell therapy for solid tumors.
03-20 21:15
美股周涨跌榜 | 与诺和诺德“世纪大和解”！Hims周内暴涨超57%；PayPay上市两日涨超32%
与诺和诺德“世纪大和解”！Hims周内暴涨超57%；近十年日企赴美最大IPO，PayPay上市两日涨超32%；获英伟达20亿美元投资，Nebius周涨超26%>>
03-14 10:29
美股周涨跌榜 | DAWN周涨一倍，获国际制药集团Servier溢价收购；Ziff Davis周涨56.3%
DAWN周涨一倍，获国际制药集团Servier溢价收购；Ziff Davis周涨56.3%，将其下属部门出售给埃森哲，获巴克莱上调其目标价；TNGX周涨52.1%，Q4亏损同比收窄超预期>>
03-07 10:50
What's Going On With Iovance Biotherapeutics Stock On Friday?
Iovance stock jumps despite no news as investors watch short interest and promising early data from its cancer therapy trial.
03-07 02:06
